ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
NCT00005594
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
ISIS 2503
Sponsor
University of Alabama at Birmingham
Collaborators
[object Object]
[object Object]